Outpatient Baloxavir Demonstrates Fewer Influenza Hospitalizations Than Oseltamivirย 

Outpatient Baloxavir Demonstrates Fewer Influenza Hospitalizations Than Oseltamivirย 

According to a U.S. retrospective analysis published in the International Journal of Infectious Diseases, real-world outcomes suggests that baloxavir may offer more reduction in downstream healthcare utilization among influenza outpatients compared to oseltamivir. The study evaluated electronic health records from 69 healthcare organizations, identifying more than 75,000 treated patients aged 5 years and older who received either oseltamivir (73,899) or baloxavir (1,592) from 2016 to 2023. Across 1-, 3-, and 6-month follow-up periods, baloxavir users …

Read More
Log In